Losing Weight RX is committed to providing our readers with clear, accurate, and evidence-based information regarding metabolic medicine, weight care therapies, and public health policy. We believe that empowering individuals with high-quality clinical news is essential to supporting their health journeys. Our content is designed to demystify complex medical topics and provide clear context around pharmaceutical and regulatory updates.
1. Publishing Principles & Editorial Mission
Our core mission is to bridge the gap between complex clinical research and patient education. To achieve this, we adhere to the following principles:
- Patient-Centric: We prioritize clarity and utility, ensuring that clinical reporting remains accessible and directly helpful for patients navigating weight care options.
- Evidence-Based: Every news report and scientific summary is grounded in published literature, official clinical trial registries, or government announcements.
- Objectivity: We report on clinical efficacy, safety profiles, and regulatory updates objectively, detailing both the benefits and the risks or side effects associated with any treatment.
2. Ethics & Independence Policy
Losing Weight RX operates under strict editorial independence guidelines. While we partner with telehealth companies and licensed pharmacy networks to fund our operations, these relationships have no influence over our news reporting or clinical assessments.
- Commercial Separation: Our editorial staff works independently of our commercial partnerships. Marketing campaigns, affiliate commissions, and advertising agreements do not dictate the selection of topics, study evaluations, or the clinical conclusions drawn in our articles.
- Conflict of Interest: Our writers and editors are required to disclose any financial relationships or conflicts of interest with pharmaceutical manufacturers or competing healthcare platforms. No writer is permitted to report on a therapeutic agent if they have a financial stake in its manufacturer.
- Affiliate Disclosure: In keeping with Federal Trade Commission (FTC) guidelines, we maintain a transparent Affiliate Disclosure detailing how referral pathways help support the free availability of our newsroom.
3. Verification & Fact-Checking Policy
Accuracy is the cornerstone of trust in medical journalism. The Losing Weight RX editorial team maintains a multi-step verification process to ensure that all published information is current, clinically precise, and reliable.
- Primary Scientific Sourcing: Our writers base their reporting on primary sources, including peer-reviewed studies published in reputable medical journals (e.g., The Lancet, The New England Journal of Medicine, Nature Aging), official clinical trial databases (ClinicalTrials.gov), government announcements (FDA, CDC, NIH), and professional medical congress presentations (ASCO, EAS, AAOS). We do not rely on secondary summaries or unsourced rumors.
- Reference Transparency: All articles include a dedicated "References" section with direct, outgoing links to the primary research papers, regulatory filings, or scientific statements cited in the text, allowing readers to verify findings independently.
- Clinical Context: When reporting on clinical trials, we distinguish between early-stage results (Phase 1 or 2) and confirmatory Phase 3 data. We also clearly report sample sizes, study populations, and primary endpoints to prevent misleading exaggerations.
4. Corrections Policy
We strive for perfect accuracy, but errors can occur. When we identify or receive reports of factual inaccuracies in our articles, we act promptly and transparently to address them.
- Reporting Errors: Readers, clinical professionals, and industry representatives are encouraged to submit correction requests to our editorial desk via email at [email protected].
- Investigation: The senior editorial team reviews all correction requests against primary sources and consults clinical literature if necessary.
- Transparency: If a material factual error is corrected, we update the live article immediately. We append a clear, dated "Correction Note" at the bottom of the article detailing the change and the correction date to maintain transparent reporting.
5. Unnamed Sources Policy
In our reporting on public health policy and pharmaceutical logistics, we occasionally consult regulatory professionals, pharmacy staff, or corporate insiders who request anonymity due to employment concerns or non-disclosure agreements.
- Anonymity Criteria: We only grant anonymity when the source possesses critical, non-public information that cannot be obtained through public records, and when they face credible career or legal risks for disclosing it.
- Verification: Any information provided by an unnamed source is subjected to rigorous independent corroboration before publication. We do not publish single-source anonymous claims regarding clinical safety or efficacy.
6. Diversity Policy
Losing Weight RX recognizes that metabolic health affects individuals differently based on socio-economic, racial, genetic, and geographic factors. Our coverage priorities reflect a commitment to reporting on diverse clinical demographics, addressing health equity in access to GLP-1 therapies, and detailing how genetic variations shape individual treatment responses.
7. Editorial Masthead
Our editorial decisions and content standards are guided by experienced health communications and research professionals:
- Senior Health & Medical Writer: Claire Bennett, MA (Johns Hopkins University) — Focuses on FDA beat, clinical drug approvals, and metabolic standards.
- Clinical Trials Research Specialist: Owen Gallagher, MS (Duke University) — Focuses on clinical trial designs, primary oncology endpoints, and evidence reviews.
- Pharmacology & Drug Science Writer: Daniel Hartley, MS (Georgetown University) — Focuses on receptor kinetics, pharmacology, and drug-drug interactions.
- Health Policy & Equity Lead: Priya Narasimhan, MPH (Columbia University) — Focuses on public policy, insurance access, and compounding regulations.
8. Actionable Feedback & Complaints
We welcome your questions, feedback, and critiques. Engaging with our audience helps us improve our coverage and ensure that we are addressing the topics that matter most to patients and healthcare providers. Please send all feedback, story suggestions, or general inquiries to [email protected].